Precise Biometrics (PREC) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Achieved fifth consecutive quarter of growth and positive EBITDA, with net sales up 7.3% in Q4 and 15.7% for the full year 2024 compared to 2023.
EBITDA improved to SEK 13.4 million for 2024 from SEK -1.7 million in 2023, with significant cash flow improvement despite a challenging market.
Strategic focus on expanding in mobile, automotive, and digital identity verticals, leveraging strengths in ultrasonic and anti-tampering technologies.
Accelerated migration to cloud solutions and increased ARR, with notable customer wins and product launches.
Financial highlights
Q4 net sales: SEK 21.8 million (up from SEK 20.3 million in Q4 2023); full-year net sales: SEK 86.9 million (up from SEK 75.1 million in 2023).
Q4 EBITDA: SEK 3.4 million (SEK 0.6 million in Q4 2023); full-year EBITDA: SEK 13.4 million (SEK -1.7 million in 2023).
Q4 EBIT: SEK -2.1 million (SEK -5.4 million in Q4 2023); full-year EBIT: SEK -9.4 million (SEK -26.5 million in 2023).
Q4 earnings per share: SEK -0.02 (SEK -0.06 in Q4 2023); full-year EPS: SEK -0.11 (SEK -0.34 in 2023).
Cash flow from operating activities: SEK 10.1 million for 2024 (SEK -10.8 million in 2023); cash and cash equivalents at year-end: SEK 37.7 million.
Outlook and guidance
Anticipates continued strong growth in 2025, driven by rising demand for security and user-friendly solutions in mobile, automotive, and digital identity markets.
Well positioned for further royalty revenue growth in ultrasonic fingerprint sensors and expansion in cloud-based digital identity solutions.
Ongoing product development and new partnerships expected to support growth and positive cash flow.
Latest events from Precise Biometrics
- Merger forms a global biometrics leader, targeting SEK 45 million in annual synergies by 2027.PREC
M&A announcement23 Mar 2026 - Positive EBITDA and cash flow achieved despite revenue decline and postponed customer volumes.PREC
Q4 202512 Feb 2026 - Positive EBITDA and stable ARR amid lower sales, with strong demand for biometric solutions.PREC
Q3 202514 Nov 2025 - Q2 saw stable sales and new biometric projects, but profitability was pressured by currency and customer shifts.PREC
Q2 202515 Aug 2025 - Q3 delivered strong growth, positive EBIT, and record margins, with robust outlook ahead.PREC
Q3 202413 Jun 2025 - Net sales and EBITDA rose, with ARR and new projects supporting growth outlook.PREC
Q2 202413 Jun 2025 - Net sales fell 7.7% in Q1 2025, but growth prospects remain strong for the year.PREC
Q1 20255 Jun 2025